Haleon plc American Depositary Shares (Each representing two Ordinary Shares) vs Philip Morris International Inc. — how do they compare? Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at $9.29 (market cap $40.01B), while Philip Morris International Inc. trades at $200.44 (market cap $312.50B). The key difference: Philip Morris International Inc. is far larger — about 7.8× Haleon plc American Depositary Shares (Each representing two Ordinary Shares)'s market cap, and Philip Morris International Inc. pays the higher dividend (3.19%). Which is the better fit depends on your goals — on Pluang, investors hold Haleon plc American Depositary Shares (Each representing two Ordinary Shares) for 0 Days and Philip Morris International Inc. for 85 Days on average.
| HLN | PM | |
|---|---|---|
Market Cap | $40.01B | $312.50B |
Volume | 19,985,935 | 5,517,172 |
Sector | Health | Consumer Staples |
52-Week High | $11.27 | $200.50 |
52-Week Low | $8.70 | $144.33 |
Typical Hold Time | 0 Days | 85 Days |
Enterprise Value | $49.79B | $355.62B |
Dividend Yield | 2.14% | 3.19% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $192.69, up 1.2% today, with a bullish technical signal and strong analyst support. Recent Q2 2026 EPS beat expectations at $2.20 vs. $2.05, and revenue growth accelerated to $40.65B in 2025. The company's smoke-free products now drive 42% of revenue, with ZYN and IQOS expansions fueling optimism. Cash flow remains robust, with 2026 operating cash flow projected at $14.3B, supporting dividend growth.
Outlook is positive given earnings momentum and smoke-free transition, but high debt ($42.17B long-term) and regulatory risks persist. The consensus price target of $212.17 implies ~10% upside, though valuation multiples are elevated versus peers. Key risks include FX volatility and slower adoption of next-gen products.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Haleon is a consumer healthcare company offering over-the-counter medicines, oral health products, vitamins, and wellness brands.
Read more on HLN →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →